Seven of eight members of 23andMe's board have resigned in yet another blow to the struggling genetics company. The CEO is now the only remaining member. The independent directors of the genetic testing firm said in a letter posted Tuesday that they were quitting the company's board after not receiving a satisfactory buyout offer from the CEO, Anne Wojcicki. "After months of work, we have yet to receive from you a fully financed, fully diligenced, actionable proposal that is in the best interests of the non ...